Related Experiment Video
Updated: Jan 17, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.0K
Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective
Daniel S Marín-Medina1, Gala Lopez2, Malco Rossi3
1Servicio de Movimientos Anormales, Departamento de Neurología Fleni, Buenos Aires, Argentina; Edmond J. Safra Program in Movement Disorders, Argentina.
Parkinsonism & Related Disorders
|September 24, 2025
Summary
Functional Movement Disorders (FMD) often change over time, typically evolving into mixed forms. Early functional dystonia may predict these phenotype shifts, highlighting the need for ongoing patient monitoring.
Area of Science:
- Neurology
- Movement Disorders
- Clinical Neuroscience
Background:
- Functional Movement Disorders (FMD) present with a variable clinical course.
- Understanding FMD phenotype evolution is crucial for prognosis and natural history insights.
Purpose of the Study:
- To investigate the longitudinal changes in FMD phenotypes.
- To identify clinical predictors of FMD phenotype modification over time.
Main Methods:
- Retrospective analysis of 112 FMD patients from a tertiary movement disorders clinic (2011-2024).
- Comparison of clinical and demographic data between patients with and without phenotype changes from initial to last consultation.
- Logistic regression analysis to identify predictors of phenotype modification.
Main Results:
- 13.2% of patients exhibited a phenotype change from initial to last consultation, predominantly shifting towards mixed FMD.
- Phenotype modification was associated with family dysfunction, within-phenotype variability, symptom migration, and poorer patient-reported status.
- Functional dystonia at initial assessment predicted phenotype modification, even after adjusting for variability.
Conclusions:
- FMD phenotypes frequently change over time, with a trend towards mixed presentations.
- Specific clinical features, such as functional dystonia, can predict these longitudinal changes.
- Continuous patient follow-up is essential for managing evolving FMD.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K

